Panel’s Rejection of PSA Test Spurs Mixed Reaction From Experts (HealthDay)

Your Health Matters

HealthDay – FRIDAY, Oct. 7 (HealthDay News) — News that a key government
advisory panel will give a thumbs-down next week to a controversial blood
test for prostate cancer is garnering both praise and condemnation from
experts.

facebookShare on Facebook
TwitterTweet
FollowFollow us
PinterestSave